Table of Contents
Volume 1 | Issue 4
Publication Date: May 2000- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
249 |
Clinical Lung Cancer A Promising Start Chandra P. Belani |
|
Meeting Highlights | ||
255-258 |
Highlights From: 10th European Cancer Conference (ECCO 10) Vienna, Austria; 17th Chemotherapy Foundation Symposium New York City, New York Angelia D. Gibson |
|
Comprehensive Reviews | ||
261-268 |
Pathological Examination and the Reporting of Lung Cancer Specimens Dean W. Chamberlain, Georg F.C. Wenckebach, Fred Alexander, Richard S. Fraser, Arnost Kolin, Toni Newman |
|
269-274 |
Adjuvant Therapy of NonSmall-Cell Lung Cancer Steven M. Keller |
|
Original Contribution | ||
277-285 |
Endoscopic Laser Ablation as Palliative Treatment of Endobronchial, Nonresectable, or Recurrent Lung Cancer: Assessment of its Impact on Quality of Life Giovanni Mantovani, Giorgio Astara, Gabriella Manca, Renato Versace, Paolo Contu, Antonio Carai |
|
Commentary | ||
286 |
Commentary on Endoscopic Laser Ablation as Palliative Treatment of Endobronchial, Nonresectable, or Recurrent Lung Cancer: Assessment of its Impact on Quality of Life Douglas E. Wood |
|
Original Contribution | ||
287-293 |
Preoperative High-Dose Cisplatin Versus Moderate-Dose Cisplatin Combined with Ifosfamide and Mitomycin in Stage IIIA (N2) NonSmall-Cell Lung Cancer: Results of a Randomized Multicenter Trial Enriqueta Felip, Rafael Rosell, Vicente Alberola, José Gómez-Codina, José Maestre, Julio Astudillo, Carlos Camps, José L. Gonzalez-Larriba, Isabel Moreno, Alfredo Paredes, Angel Artal, Ramón García-Gómez, Pilar Garrido, Felipe Cardenal, Isidoro Barneto, José J. Sánchez |
|
Translational Medicine | ||
294-301 |
Cancer Vaccines for the Treatment and Prevention of NonSmall-Cell Lung Cancer Mary L. Disis, Howard L. West, Kathy Schiffman |
|
Current Trials | ||
302-304 |
Manganese Superoxide Dismutase-Plasmid/Liposome (MnSOD-PL) Gene Therapy Protection of the Esophagus from Chemoradiotherapy Damage During Treatment of Locally Unresectable NonSmall-Cell Lung Cancer (NSCLC) Joel S. Greenberger, Michael Epperly, James Luketich, William Gooding, Chandra P. Belani |
|
Brief Communication | ||
310-311 |
A Phase I Trial of Outpatient Weekly Irinotecan/Carboplatin and Concurrent Radiation for Stage III Unresectable NonSmall-Cell Lung Cancer: A Vanderbilt-Ingram Cancer Center Affiliate Network Trial A. Chakravarthy, Hak Choy |
|
Letter to the Editor | ||
312 |
letter to the editor Michael C. Perry |